<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000674701"><TermName>GSK1070916A</TermName><TermDefinition><DefinitionText>A substance
          being studied in the treatment of some types of cancer. It
          blocks certain enzymes (Aurora kinases) involved in cell
          division and may kill cancer cells. It is a type of
          serine/threonine protein kinase inhibitor. Also called Aurora B/C kinase inhibitor GSK1070916A.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>GSK1070916A</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de ciertos tipos de cáncer. Impide el funcionamiento de ciertas enzimas (Cinasas de la aurora ) que participan en la multiplicación celular y podría eliminar las células cancerosas. Es un tipo de inhibidor de la proteína cinasa serina/treonina. También se llama inhibidor de la cinasa de la aurora B y C GSK1070916A.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-10-11</DateFirstPublished></GlossaryTerm>
